• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英国,激励性初级保健指标的达标情况与威胁视力的糖尿病视网膜病变的发生之间的关联:一项基于人群的历史队列研究。

Associations between attainment of incentivized primary care indicators and incident sight-threatening diabetic retinopathy in England: A population-based historical cohort study.

机构信息

Department of Primary Care and Public Health, Imperial College London, London, UK.

Department of Public Health Sciences and School of Data Science, University of North Carolina (UNC) at Charlotte, Charlotte, North Carolina, USA.

出版信息

Diabetes Obes Metab. 2021 Jun;23(6):1322-1330. doi: 10.1111/dom.14344. Epub 2021 Mar 3.

DOI:10.1111/dom.14344
PMID:33565708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8350793/
Abstract

AIM

To examine the impact of attainment of primary care diabetes clinical indicators on progression to sight-threatening diabetic retinopathy (STDR) among those with mild non-proliferative diabetic retinopathy (NPDR).

MATERIALS AND METHODS

An historical cohort study of 18,978 adults (43.63% female) diagnosed with type 2 diabetes before 1 April 2010 and mild NPDR before 1 April 2011 was conducted. The data were obtained from the UK Clinical Practice Research Datalink during 2010-2017, provided by 330 primary care practices in England. Exposures included attainment of the Quality and Outcomes Framework HbA1c (≤59 mmol/mol [≤7.5%]), blood pressure (≤140/80 mmHg) and cholesterol (≤5 mmol/L) indicators in the financial year 2010-2011, as well as the number of National Diabetes Audit processes completed in 2010-2011. The outcome was time to incident STDR. Nearest neighbour propensity score matching was undertaken, and univariable and multivariable Cox proportional hazards models were then fitted using the matched samples. Concordance statistics were calculated for each model.

RESULTS

A total of 1037 (5.5%) STDR diagnoses were observed over a mean follow-up of 3.6 (SD 2.0) years. HbA1c, blood pressure and cholesterol indicator attainment were associated with lower rates of STDR (adjusted hazard ratios [95% CI] 0.64 [0.55-0.74; p < .001], 0.83 [0.72-0.94; p = .005] and 0.80 [0.66-0.96; p = .015], respectively).

CONCLUSIONS

Our findings provide support for meeting appropriate indicators for the management of type 2 diabetes in primary care to bring a range of benefits, including improved health outcomes-such as a reduction in the risk of STDR-for people with type 2 diabetes.

摘要

目的

研究在患有轻度非增殖性糖尿病视网膜病变(NPDR)的患者中,达到初级保健糖尿病临床指标对向威胁视力的糖尿病性视网膜病变(STDR)进展的影响。

材料和方法

这是一项历史队列研究,纳入了 18978 名成年患者(43.63%为女性),他们在 2010 年 4 月 1 日之前被诊断为 2 型糖尿病,在 2011 年 4 月 1 日之前被诊断为轻度 NPDR。数据来自于 2010-2017 年期间英国临床实践研究数据链接,由英格兰 330 个初级保健实践提供。暴露因素包括在 2010-2011 财年达到质量和结果框架 HbA1c(≤59mmol/mol[≤7.5%])、血压(≤140/80mmHg)和胆固醇(≤5mmol/L)指标,以及在 2010-2011 年完成的国家糖尿病审计过程数量。结果是出现新的 STDR 的时间。采用最近邻居倾向评分匹配,然后使用匹配样本拟合单变量和多变量 Cox 比例风险模型。为每个模型计算了一致性统计量。

结果

在平均 3.6(标准差 2.0)年的随访中,共观察到 1037 例(5.5%)STDR 诊断。HbA1c、血压和胆固醇指标的达标与较低的 STDR 发生率相关(调整后的风险比[95%置信区间]分别为 0.64[0.55-0.74;p<0.001]、0.83[0.72-0.94;p=0.005]和 0.80[0.66-0.96;p=0.015])。

结论

我们的研究结果为初级保健中管理 2 型糖尿病达到适当指标提供了支持,这为 2 型糖尿病患者带来了一系列益处,包括改善健康结果,如降低 STDR 风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b64/8350793/f4310fddbf94/DOM-23-1322-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b64/8350793/f4310fddbf94/DOM-23-1322-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b64/8350793/f4310fddbf94/DOM-23-1322-g001.jpg

相似文献

1
Associations between attainment of incentivized primary care indicators and incident sight-threatening diabetic retinopathy in England: A population-based historical cohort study.在英国,激励性初级保健指标的达标情况与威胁视力的糖尿病视网膜病变的发生之间的关联:一项基于人群的历史队列研究。
Diabetes Obes Metab. 2021 Jun;23(6):1322-1330. doi: 10.1111/dom.14344. Epub 2021 Mar 3.
2
Associations between attainment of incentivised primary care indicators and incident diabetic retinopathy in England: a population-based historical cohort study.激励性初级保健指标的实现与英国糖尿病视网膜病变发病的关联:基于人群的历史队列研究。
BMC Med. 2021 Apr 16;19(1):93. doi: 10.1186/s12916-021-01966-x.
3
Associations between attainment of incentivized primary care indicators and incident lower limb amputation among those with type 2 diabetes: a population-based historical cohort study.激励性初级保健指标的实现与 2 型糖尿病患者下肢截肢事件的相关性:基于人群的历史队列研究。
BMJ Open Diabetes Res Care. 2021 Apr;9(1). doi: 10.1136/bmjdrc-2020-002069.
4
Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.2型糖尿病患者肾功能指标与威胁视力的糖尿病视网膜病变之间的相关性:一项针对印度门诊患者的纵向研究
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2020-001325.
5
Associations between attainment of incentivised primary care indicators and emergency hospital admissions among type 2 diabetes patients: a population-based historical cohort study.激励型初级保健指标的达标情况与 2 型糖尿病患者急诊住院之间的关联:一项基于人群的历史队列研究。
J R Soc Med. 2021 Jun;114(6):299-312. doi: 10.1177/01410768211005109. Epub 2021 Apr 6.
6
Associations between attainment of incentivised primary care diabetes indicators and mortality in an English cohort.英国队列中初级保健糖尿病激励指标的达成情况与死亡率之间的关联。
Diabetes Res Clin Pract. 2021 Apr;174:108746. doi: 10.1016/j.diabres.2021.108746. Epub 2021 Mar 10.
7
Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.印度的糖尿病眼病研究(SPEED)。报告#2. 印度 2 型糖尿病患者的糖尿病视网膜病变及威胁视力的糖尿病视网膜病变的危险因素。
Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S21-S26. doi: 10.4103/ijo.IJO_21_19.
8
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.在糖尿病眼病筛查中,威胁视力的糖尿病视网膜病变进展率的种族差异:一项基于人群的回顾性队列研究。
BMJ Open Diabetes Res Care. 2023 Nov;11(6). doi: 10.1136/bmjdrc-2023-003683.
9
Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.在既定的城市筛查计划中,威胁视力的糖尿病视网膜病变的发病率:一项为期 11 年的队列研究。
Diabet Med. 2021 Sep;38(9):e14583. doi: 10.1111/dme.14583. Epub 2021 Jun 9.
10
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.

引用本文的文献

1
Involvement of transient receptor potential channels in ocular diseases: a narrative review.瞬时受体电位通道在眼部疾病中的作用:一篇叙述性综述。
Ann Transl Med. 2022 Aug;10(15):839. doi: 10.21037/atm-21-6145.
2
Ethnic Disparities in the Development of Sight-Threatening Diabetic Retinopathy in a UK Multi-Ethnic Population with Diabetes: An Observational Cohort Study.英国多民族糖尿病患者中威胁视力的糖尿病视网膜病变发展的种族差异:一项观察性队列研究
J Pers Med. 2021 Jul 28;11(8):740. doi: 10.3390/jpm11080740.

本文引用的文献

1
Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.应对糖尿病视网膜病变全球负担的策略:从流行病学到人工智能。
Ophthalmologica. 2020;243(1):9-20. doi: 10.1159/000502387. Epub 2019 Aug 13.
2
Update on Screening for Sight-Threatening Diabetic Retinopathy.筛查威胁视力的糖尿病视网膜病变进展。
Ophthalmic Res. 2019;62(4):218-224. doi: 10.1159/000499539. Epub 2019 May 27.
3
Incidence and progression of diabetic retinopathy: a systematic review.糖尿病视网膜病变的发病和进展:系统评价。
Lancet Diabetes Endocrinol. 2019 Feb;7(2):140-149. doi: 10.1016/S2213-8587(18)30128-1. Epub 2018 Jul 11.
4
Effects of lipid-lowering agents on diabetic retinopathy: a Meta-analysis and systematic review.降脂药物对糖尿病视网膜病变的影响:一项Meta分析与系统评价
Int J Ophthalmol. 2018 Feb 18;11(2):287-295. doi: 10.18240/ijo.2018.02.18. eCollection 2018.
5
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.52 周时玻璃体内注射阿柏西普与全视网膜光凝治疗增生性糖尿病视网膜病变患者最佳矫正视力的临床疗效(CLARITY):一项多中心、单盲、随机、对照、2b 期、非劣效性临床试验。
Lancet. 2017 Jun 3;389(10085):2193-2203. doi: 10.1016/S0140-6736(17)31193-5. Epub 2017 May 7.
6
The English National Screening Programme for diabetic retinopathy 2003-2016.2003 - 2016年英国糖尿病视网膜病变国家筛查计划
Acta Diabetol. 2017 Jun;54(6):515-525. doi: 10.1007/s00592-017-0974-1. Epub 2017 Feb 22.
7
Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom.与英国国家调查和登记数据相比,利用基层医疗电子健康记录评估肾功能下降和肾脏替代治疗患病率的有效性。
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii142-ii150. doi: 10.1093/ndt/gfw318.
8
Mini Review: Changes in the Incidence of and Progression to Proliferative and Sight-Threatening Diabetic Retinopathy Over the Last 30 Years.综述:过去30年增殖性及威胁视力的糖尿病视网膜病变的发病率变化及病情进展
Ophthalmic Epidemiol. 2017 Apr;24(2):73-80. doi: 10.1080/09286586.2016.1259638. Epub 2017 Jan 19.
9
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿:一项比较疗效随机临床试验的两年结果。
Ophthalmology. 2016 Jun;123(6):1351-9. doi: 10.1016/j.ophtha.2016.02.022. Epub 2016 Feb 27.
10
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.开发用于优化糖尿病视网膜病变筛查间隔的成本效益模型。
Health Technol Assess. 2015 Sep;19(74):1-116. doi: 10.3310/hta19740.